Cathal Berry (Kildare South, Independent) | Oireachtas source

My question is specific to the Government's vaccination roll-out strategy, particularly the fourth vaccine candidate from Janssen and Johnson & Johnson. Most of the Deputies present may not be aware but it will only require one injection rather than the usual two. Were it to be approved, it would greatly accelerate and simplify the vaccine roll-out process. The US Food and Drug Administration is likely to approve this vaccine candidate in the next ten days or so.

From his European contacts, does the Taoiseach have any visibility as to when Johnson & Johnson will submit its literature concerning this vaccine candidate to the European Medicines Agency for approval? If the Taoiseach has any thoughts on this, it would be much appreciated.

See this speech in context